entertainment -WSS

entertainment

author：knowledge 2025-09-06 01:59:20 - browse：6938

a stethoscope and money – hospitals and health insurance coverage from STAT — Bright Health is officially leaving the health insurance market. The company has agreed to sell its Medicare Advantage plans to Molina Healthcare. Adobe

Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare.

Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.

Molina agreed to pay $600 million for Bright’s 125,000 California Medicare Advantage enrollees, which equates to about $4,800 for each person. The federal government paid insurance companies almost $12,000, on average, for each MA enrollee in 2022. Molina said in a news release that Bright’s current book of business generates $1.8 billion of revenue, or more than $14,000 for each member.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Report: NIH

WSS

ALS patient reclaims some autonomy thanks to wearable 'robot'

iTeos Therapeutics debuts first data on TIGIT

How faith leaders like me can help address America's obesity epidemic

My daughter's legacy lives on through her writing, phage therapy

The system is set up to fail children with medical complexity

My daughter's legacy lives on through her writing, phage therapy

leisure time

entertainment

focus

How to save PrEP access — and even expand it

Average age of first period drops to 11.9 years, study shows

In age of alternative facts, a scholarly course on calling out crap

'Essentially witchcraft:' A former naturopath takes on the field

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

My daughter's legacy lives on through her writing, phage therapy

DIEP, the 'gold standard' of breast reconstruction, is under threat

Dark money group runs ads on China biotech bill

Novavax promises a turnaround & Lilly roils the obesity market

Readers discuss the intersection of pregnancy and addiction

leisure time

Adam's Biotech Scorecard: Do Sarepta's exon

AI used to predict Covid

My daughter's legacy lives on through her writing, phage therapy

Report captures long Covid’s disabling effects and policy challenges

Curing rare childhood diseases will falter unless Congress steps up

Moderna says combo Covid

focus

entertainment

leisure time

hotspot